Planners and authors for this course had no disclosures.
Quality Improvement Committee
Elizabeth J. Angus, MD- no disclosures
Michele L. Arnold, MD- no disclosures
Lorna A. Brock, CNCT, R.NCS.T- no disclosures
Mohammad A. Choudhry, MD- no disclosures
David R. Del Toro, MD- no disclosures
Segun T. Dawodu, MD, JD, MBA, LL.M, MS- no disclosures
Nida G. Gleveckas-Martens, DO- no disclosures
Ana M. Hess, CNCT, R.NCS.T- no disclosures
Lyell K. Jones, MD- no disclosures
Nanette C. Joyce, DO- no disclosures
Charles D. Kassardjian, MD- no disclosures
John C. Kincaid, MD- no disclosures
Kerry H. Levin, MD- no disclosures
Michelle A. McFarlane, MD- no disclosures
Pushpa Narayanaswami, MBBS, DM, FAAN- (Committee Chair)- no disclosures
Kenkichi Nozaki, MD, PhD- no disclosures
David B. Rosenfield, MD- no disclosures
Renee A. Schwarz, CNCT, R. NCST., R. EEG T., R. EP T.,C.M.E.T.- no disclosures
Dan Y. Shamir, MD- no disclosures
Michael D. Stubblefield, MD- no disclosures
Sasha Zivkovic, MD- no disclosures
Carrie Winter (staff)- no disclosures
THE AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY HAS REVIEWED THE PERFORMANCE IN PRACTICE: CARPAL TUNNEL SYNDROME AND HAS APPROVED THIS ACTIVITY AS PART OF A COMPREHENSIVE IMPROVEMENT IN MEDICAL PRACTICE (PIP) ACTIVITY, WHICH IS MANDATED BY THE ABMS AS A NECESSARY COMPONENT OF CONTINUING CERTIFICATION.
The American Board of Physical Medicine & Rehabilitation has approved this activity for QI/IHHC credit.